The companies continue to work to secure Lyumjev compatibility for the t:slim X2 pump in other regions and to secure Lyumjev compatibility for the Tandem Mobi pump. Please see Lyumjev Full ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery ...

RBC sets a $65 price target for Tandem, citing strong growth prospects and margin improvements. RBC expects 51% gross margins in 2024, with the Mobi pump launch driving long-term profitability.

SAN DIEGO, September 19, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump ...

After hours: October 14 at 5:49 PM EDT Loading Chart for TNDM ...

Tandem OLED has been around for years, but Apple made the technology feel new and shiny when it announced that the screen in its first ever OLED-based iPad would use a tandem structure. Other ...

Although Lyumjev earned its approval in the 27-nation body back in 2020, the stringent testing the EU requires of pump manufacturers meant Tandem's product needed some time to catch up.

Are rapid antigen at-home tests, not PCR Can be taken at home or other locations. Give results within 30 minutes (no lab drop-off required) Can be used for testing even if you do not have COVID-19 ...